✦ LIBER ✦

Taxol and cisplatin (TP) versus etoposide cisplatin (EP) in advanced non-small cell lung cancer (NSCLC)

✍ Scribed by T.E. Ciuleanu; C. Cebotaru; I. Radulescu; N. Todor; N. Ghilezan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Concomitant cisplatin, etoposide and rad

✍ Reboul, F.; Vincent, P.; Chauvet, B.; Brewer, Y.; Félix Faure, C.; Taulelle, M. 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 195 KB

Paclitaxel/cisplatin in advanced non-sma

📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Ifosfamide, cisplatin and etoposide in a

✍ Camps, C; Berrocal, A.; Vicent, J.M.; Godes, M. 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 166 KB

Gemcitabine and cisplatin for advanced n

✍ Casal, J.; Grande, C.; Caeiro, M. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 270 KB

Prolonged oral etoposide in combination

✍ Park, K; Kim, K; Jeong, HS; Lee, JT; Kim, WS; Yoon, SS; Kang, WK; Lee, HG; Kim, 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 239 KB

Oral etoposide preceding cisplatin in ad

✍ Focan, C.; Vandermoten, G.; Boossy, J.; Schallier, D. 📂 Article 📅 1988 🏛 Elsevier Science ⚖ 571 KB